NO20005588L - Inhibisjon av Helicobacter Pylori proliferasjon - Google Patents

Inhibisjon av Helicobacter Pylori proliferasjon

Info

Publication number
NO20005588L
NO20005588L NO20005588A NO20005588A NO20005588L NO 20005588 L NO20005588 L NO 20005588L NO 20005588 A NO20005588 A NO 20005588A NO 20005588 A NO20005588 A NO 20005588A NO 20005588 L NO20005588 L NO 20005588L
Authority
NO
Norway
Prior art keywords
somatostatin
inhibition
proliferation
helicobacter pylori
pylori
Prior art date
Application number
NO20005588A
Other languages
English (en)
Other versions
NO20005588D0 (no
Inventor
Hiroshi Kaneko
Terunori Mitsuma
Koichi Yamashita
Barry A Morgan
Original Assignee
Sod Conseils Rech Applic
Hiroshi Kaneko
Terunori Mitsuma
Koichi Yamashita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Hiroshi Kaneko, Terunori Mitsuma, Koichi Yamashita filed Critical Sod Conseils Rech Applic
Publication of NO20005588D0 publication Critical patent/NO20005588D0/no
Publication of NO20005588L publication Critical patent/NO20005588L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det er beskrevet en fremgangsmåte for anvendelse av somatostatin eller en somatostatin agonist for å inhibere proliferasjon av Helicobacter pylori (H. pylori), som omfatter administrering til en pasient som trenger det en effektiv mengde av nevnte somastotatin eller somatostatin agonist. Det er foretrukket at en somatostatin sub-type resepter 2 (SSTR-2) selektiv somatostatin agonist blir administrert i en fremgangsmåte som beskrevet heri. Inhibisjon av H. pylori proliferasjon er nyttig ved behandling av forskjellige gastroduodenal sykdommer så som peptisk sår, mage cancer og gastrisk lymfom.
NO20005588A 1998-05-07 2000-11-06 Inhibisjon av Helicobacter Pylori proliferasjon NO20005588L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/074,117 US5968903A (en) 1998-05-07 1998-05-07 Inhibition of H. pylori proliferation
PCT/US1999/010058 WO1999056769A2 (en) 1998-05-07 1999-05-06 Inhibition of helicobacter pylori proliferation

Publications (2)

Publication Number Publication Date
NO20005588D0 NO20005588D0 (no) 2000-11-06
NO20005588L true NO20005588L (no) 2001-01-05

Family

ID=22117835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005588A NO20005588L (no) 1998-05-07 2000-11-06 Inhibisjon av Helicobacter Pylori proliferasjon

Country Status (6)

Country Link
US (1) US5968903A (no)
EP (1) EP1075273A2 (no)
JP (1) JP2002513769A (no)
AU (1) AU3975499A (no)
NO (1) NO20005588L (no)
WO (1) WO1999056769A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243552C1 (en) * 2001-01-12 2006-08-31 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
DE60220157T2 (de) * 2001-03-06 2008-01-17 Il Consorzio Ferrara Richerche Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
AU2002362030A1 (en) * 2001-11-27 2003-06-10 Fred Hutchinson Cancer Research Center Methods for inhibiting deacetylase activity
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
JP2007518702A (ja) * 2003-11-25 2007-07-12 ノバルティス アクチエンゲゼルシャフト ソマトスタチン類似体処置の効力についてのバイオマーカー
CA2727082C (en) 2008-06-12 2019-02-26 Syntaxin Limited Fusion proteins for use in suppression of acromegaly
CN102083451A (zh) 2008-06-12 2011-06-01 赛恩泰新公司 癌症的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
US4190575A (en) * 1977-12-27 1980-02-26 American Home Products Corporation Polypeptides related to somatostatin
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
DK153293C (da) * 1977-07-22 1988-11-14 Stamicarbon Katalysator til dehydrogenering af organiske forbindelser, isaer aminer, thioler og alkoholer, og fremgangsmaade til fremstilling deraf
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
US4215039A (en) * 1979-02-15 1980-07-29 American Home Products Corporation Somatostatin analogues
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4209426A (en) * 1979-05-29 1980-06-24 American Home Products Corporation Polypeptides related to somatostatin
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
US4358439A (en) * 1979-12-21 1982-11-09 Ciba-Geigy Corporation Cyclooctapeptides
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
EP0083305B1 (de) * 1981-12-24 1985-07-10 Ciba-Geigy Ag Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
FR2522655B1 (fr) * 1982-03-05 1987-03-06 Sanofi Sa Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
US4486415A (en) * 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
EP0329295A1 (en) * 1988-02-01 1989-08-23 The Upjohn Company Renin inhibiting peptides with polar end groups
ZA895838B (en) * 1988-08-18 1991-03-27 Syntex Inc Pharmaceutical compounds
CA2012115C (en) * 1989-03-15 2001-07-03 Biomeasure, Inc. Iodinated somatostatins
CA2053250A1 (en) * 1989-04-26 1990-10-27 David H. Coy Linear somatostatin analogs
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
RO117259B1 (ro) * 1993-08-09 2001-12-28 Biomeasure Inc. Derivaţi peptidici, terapeutici
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
WO1998008528A1 (en) * 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
AU4133997A (en) * 1996-09-12 1998-04-02 Yarom Cohen Pharmaceutical composition for the treatment of syndrome x of reaven

Also Published As

Publication number Publication date
WO1999056769A3 (en) 2000-11-09
US5968903A (en) 1999-10-19
AU3975499A (en) 1999-11-23
EP1075273A2 (en) 2001-02-14
WO1999056769A2 (en) 1999-11-11
JP2002513769A (ja) 2002-05-14
NO20005588D0 (no) 2000-11-06

Similar Documents

Publication Publication Date Title
WO2002015722A3 (en) Treatment of helicobacter with isothiocyanates
NO20005588L (no) Inhibisjon av Helicobacter Pylori proliferasjon
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
NO20024011L (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
JP2004519423A5 (no)
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
IL157821A0 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
NO940266L (no) Indre strålingsskade
DK0514452T3 (da) Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
FI20011403A7 (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
WO2003024391A3 (en) Treatment and prevention of mucositis in cancer patients
NO980221L (no) Fremgangsmåte for behandling av tykktarmsadenomer
IS4907A (is) Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær
AU6580494A (en) Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
WO1999057278A3 (en) IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
AU6701998A (en) Method for treatment of (h. pylori)
NZ282804A (en) Use of dimethylpolysiloxane (dimeticone) for treating helicobacter pylori infections
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt
EP1002805A4 (en) HELICOBACTER PYLORI FIXING INHIBITORS
NO964252L (no) Anvendelsen av spiramycin for behandling av gastrointestinale mangler som forårsaket av H.pylori

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application